Delivery Order SPE2DB22D3501-SPE2DB25FXM11
Award Date 9/22/25
Potential Completion Date 10/14/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lorbrena 100 mg tablets in quantities of 30. This firm fixed-price delivery order, valued at $11,624.35, represents a competitive award with no set-aside designation and is scheduled for completion by September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lorbrena 100 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lorbrena 100mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $23,248.70, is scheduled for completion by August 11, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Lorbrena 25 mg tablets (30-count) on September 22, 2025, with a ceiling value of $11,624.34 and an ultimate completion date of October 14, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $23,248.72 on September 5, 2025, for the supply of Lorbrena 100 mg tablets (30-count units). This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 26, 2025, and involves performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award contains no set-aside designation, reflecting AmerisourceBergen's...
- This delivery order, valued at $23,248.70 with a firm fixed price structure, was awarded to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lorbrena 100mg tablets (30-count units). The award is a non-set-aside, competitively awarded contract performed in Conshohocken, Pennsylvania, and funded through the Defense Logistics Agency's Medical Supply Chain, which supports pharmaceutical procurement for military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,384.31 by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract, issued on July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $30,056.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The delivery order will...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $10,389.40 by the Defense Logistics Agency's Medical Supply Chain on September 26, 2025, with an ultimate completion date of September 29, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026. The delivery order will...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lazicluze 240 mg tablets (30-count units) with a ceiling value of $12,446.16. This firm fixed-price delivery order, with an ultimate completion date of July 9, 2025, represents a non-competitive set-aside transaction executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...